Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 262

1.

Influence of HLA 1-3-locus mismatch and antithymocyte globulin administration in unrelated bone marrow transplantation.

Kawamura K, Kanda J, Ohashi K, Fukuda T, Iwato K, Eto T, Fujiwara SI, Mori T, Fukushima K, Ozawa Y, Uchida N, Ashida T, Ichinohe T, Atsuta Y, Kanda Y.

Ann Hematol. 2020 Mar 23. doi: 10.1007/s00277-020-03995-7. [Epub ahead of print]

PMID:
32206853
2.

Reduced-intensity stem cell transplantation for acute myeloid leukemia with fludarabine-based conditioning with intravenous busulfan versus melphalan.

Yamashita T, Takami A, Uchida N, Fukuda T, Eto T, Shiratori S, Ota S, Akasaka T, Miyakoshi S, Kondo T, Hidaka M, Kanda J, Atsuta Y, Yano S.

Bone Marrow Transplant. 2020 Mar 12. doi: 10.1038/s41409-020-0856-y. [Epub ahead of print]

PMID:
32203256
3.

Heterogeneous impact of cytomegalovirus reactivation on nonrelapse mortality in hematopoietic stem cell transplantation.

Kaito S, Nakajima Y, Hara K, Toya T, Nishida T, Uchida N, Mukae J, Fukuda T, Ozawa Y, Tanaka M, Ikegame K, Katayama Y, Kuriyama T, Kanda J, Atsuta Y, Ogata M, Taguchi A, Ohashi K.

Blood Adv. 2020 Mar 24;4(6):1051-1061. doi: 10.1182/bloodadvances.2019000814.

4.

Wide availability of HLA-matched or a few loci-mismatched donors in the graft-vs-host direction among non-sibling first-degree relatives.

Watanabe M, Kanda J, Kojima H, Ikeda N, Fuji S, Kanda Y, Saji H, Tanaka H.

HLA. 2020 Mar 13. doi: 10.1111/tan.13864. [Epub ahead of print]

PMID:
32170853
5.

Effect of graft-versus-host disease on outcomes after pediatric single cord blood transplantation.

Kanda J, Umeda K, Kato K, Murata M, Sugita J, Adachi S, Koh K, Noguchi M, Goto H, Yoshida N, Sato M, Koga Y, Hori T, Cho Y, Ogawa A, Inoue M, Hashii Y, Atsuta Y, Teshima T; JSHCT GVHD Working Group.

Bone Marrow Transplant. 2020 Mar 11. doi: 10.1038/s41409-020-0853-1. [Epub ahead of print]

PMID:
32161321
6.

Reconstruction of radiocesium levels in sediment off Fukushima: Simulation analysis of bioavailability using parameters derived from observed 137Cs concentrations.

Tateda Y, Misumi K, Tsumune D, Aoyama M, Hamajima Y, Kanda J, Ishimaru T, Aono T.

J Environ Radioact. 2020 Apr;214-215:106172. doi: 10.1016/j.jenvrad.2020.106172. Epub 2020 Feb 1.

7.

Comparison of the outcomes after haploidentical and cord blood salvage transplantations for graft failure following allogeneic hematopoietic stem cell transplantation.

Harada K, Fuji S, Seo S, Kanda J, Ueki T, Kimura F, Kato K, Uchida N, Ikegame K, Onizuka M, Matsuoka KI, Doki N, Kawakita T, Onishi Y, Yano S, Fukuda T, Takanashi M, Kanda Y, Atsuta Y, Ogata M; transplant complications working group of the Japan Society for Hematopoietic Cell Transplantation.

Bone Marrow Transplant. 2020 Feb 12. doi: 10.1038/s41409-020-0821-9. [Epub ahead of print]

PMID:
32051535
9.

Outcomes and Prognostic Factors for Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia Who Underwent Allogeneic Hematopoietic Cell Transplantation: A KSGCT Multicenter Analysis.

Tachibana T, Kanda J, Ishizaki T, Najima Y, Tanaka M, Doki N, Fujiwara SI, Kimura SI, Onizuka M, Takahashi S, Saito T, Mori T, Fujisawa S, Sakaida E, Matsumoto K, Aotsuka N, Gotoh M, Watanabe R, Shono K, Usuki K, Tsukada N, Kanamori H, Kanda Y, Okamoto S; Kanto Study Group for Cell Therapy (KSGCT).

Biol Blood Marrow Transplant. 2020 Jan 18. pii: S1083-8791(20)30018-5. doi: 10.1016/j.bbmt.2020.01.007. [Epub ahead of print]

PMID:
31962165
10.

Improvement of early mortality in single-unit cord blood transplantation for Japanese adults from 1998 to 2017.

Konuma T, Kanda J, Inamoto Y, Hayashi H, Kobayashi S, Uchida N, Sugio Y, Tanaka M, Kobayashi H, Kouzai Y, Takahashi S, Eto T, Mukae J, Matsuhashi Y, Fukuda T, Takanashi M, Kanda Y, Atsuta Y, Kimura F.

Am J Hematol. 2019 Dec 17. doi: 10.1002/ajh.25705. [Epub ahead of print]

PMID:
31849102
11.

Automated colorimetric determination of nanomolar urea in seawater by gas-segmented continuous flow analysis using a liquid waveguide capillary cell.

Takeda N, Hashihama F, Kanda J.

Talanta. 2020 Feb 1;208:120371. doi: 10.1016/j.talanta.2019.120371. Epub 2019 Sep 19.

PMID:
31816767
12.

Impact of HLA Allele Mismatch at HLA-A, -B, -C, and -DRB1 in Single Cord Blood Transplantation.

Yokoyama H, Morishima Y, Fuji S, Uchida N, Takahashi S, Onizuka M, Tanaka M, Yuju O, Eto T, Ozawa Y, Takada S, Takanashi M, Kato K, Kanda Y, Ichinohe T, Atsuta Y, Kanda J; HLA Working Group of the Japan Society for Hematopoietic Cell Transplantation.

Biol Blood Marrow Transplant. 2020 Mar;26(3):519-528. doi: 10.1016/j.bbmt.2019.11.001. Epub 2019 Nov 9.

PMID:
31715305
13.

Outcomes of allogeneic stem cell transplantation for DLBCL: a multi-center study from the Kyoto Stem Cell Transplantation Group.

Izumi K, Kanda J, Nishikori M, Arai Y, Ishikawa T, Yoshioka S, Ueda Y, Maeda T, Yonezawa A, Anzai N, Moriguchi T, Imada K, Akasaka T, Nohgawa M, Itoh M, Aiba A, Tsunemine H, Watanabe M, Kondo T, Takaori-Kondo A.

Ann Hematol. 2019 Dec;98(12):2815-2823. doi: 10.1007/s00277-019-03835-3. Epub 2019 Nov 12.

PMID:
31713653
14.

Effect of the severity of acute graft-versus-host disease on physical function after allogeneic hematopoietic stem cell transplantation.

Hamada R, Kondo T, Murao M, Miyasaka J, Yoshida M, Nankaku M, Kanda J, Takaori-Kondo A, Ikeguchi R, Matsuda S.

Support Care Cancer. 2019 Nov 12. doi: 10.1007/s00520-019-05124-1. [Epub ahead of print]

PMID:
31712955
15.

Increased Relapse Risk of Acute Lymphoid Leukemia in Homozygous HLA-C1 Patients after HLA-Matched Allogeneic Transplantation: A Japanese National Registry Study.

Arima N, Kanda J, Yabe T, Morishima Y, Tanaka J, Kako S, Sakaguchi H, Kato M, Ohashi K, Ozawa Y, Fukuda T, Ota S, Tachibana T, Onizuka M, Ichinohe T, Atsuta Y, Kanda Y.

Biol Blood Marrow Transplant. 2020 Mar;26(3):431-437. doi: 10.1016/j.bbmt.2019.10.032. Epub 2019 Nov 6.

PMID:
31704471
16.

Observation of Dispersion in the Japanese Coastal Area of Released 90Sr, 134Cs, and 137Cs from the Fukushima Daiichi Nuclear Power Plant to the Sea in 2013.

Tazoe H, Yamagata T, Tsujita K, Nagai H, Obata H, Tsumune D, Kanda J, Yamada M.

Int J Environ Res Public Health. 2019 Oct 24;16(21). pii: E4094. doi: 10.3390/ijerph16214094.

17.

Effect of Calcium Treatment on Catabolic Rates of 13C-Labeled Fatty Acids Bound to the α and β Positions of Triacylglycerol.

Yoshinaga K, Beppu F, Yamatani Y, Kubo A, Yoshinaga-Kiriake A, Nagai T, Yoshida A, Kanda J, Gotoh N.

J Oleo Sci. 2019 Nov 7;68(11):1149-1155. doi: 10.5650/jos.ess19197. Epub 2019 Oct 15.

18.

Effects of Haplotype Matching on Outcomes after Adult Single-Cord Blood Transplantation.

Kanda J, Kawase T, Tanaka H, Kojima H, Morishima Y, Uchida N, Nagafuji K, Matsuhashi Y, Ohta T, Onizuka M, Sakura T, Takahashi S, Miyakoshi S, Kobayashi H, Eto T, Tanaka J, Ichinohe T, Atsuta Y, Morishima S; HLA Working Group of the Japan Society for Hematopoietic Cell Transplantation.

Biol Blood Marrow Transplant. 2020 Mar;26(3):509-518. doi: 10.1016/j.bbmt.2019.09.035. Epub 2019 Oct 9.

PMID:
31605821
19.

Time-Varying Effects of Graft Type on Outcomes for Patients with Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation.

Yanada M, Konuma T, Yamasaki S, Kuwatsuka Y, Masuko M, Tanaka M, Ozawa Y, Toya T, Fukuda T, Ota S, Sawa M, Uchida N, Nakamae H, Eto T, Kanda J, Takanashi M, Kanda Y, Atsuta Y, Yano S.

Biol Blood Marrow Transplant. 2020 Feb;26(2):307-315. doi: 10.1016/j.bbmt.2019.09.036. Epub 2019 Oct 9.

PMID:
31605818
20.

Conditioning Intensity for Allogeneic Hematopoietic Cell Transplantation in Acute Myeloid Leukemia Patients with Poor-Prognosis Cytogenetics in First Complete Remission.

Konuma T, Kondo T, Mizuno S, Doki N, Aoki J, Fukuda T, Tanaka M, Sawa M, Katayama Y, Uchida N, Ozawa Y, Morishige S, Matsuoka KI, Ichinohe T, Onizuka M, Kanda J, Atsuta Y, Yanada M; Adult Acute Myeloid Leukemia Working Group of the Japan Society for Hematopoietic Cell Transplantation.

Biol Blood Marrow Transplant. 2020 Mar;26(3):463-471. doi: 10.1016/j.bbmt.2019.09.025. Epub 2019 Sep 25.

PMID:
31562960
21.

Allogeneic hematopoietic cell transplantation in patients with untreated acute myeloid leukemia: a KSGCT multicenter retrospective analysis.

Tachibana T, Ishizaki T, Takahashi S, Najima Y, Kimura SI, Sakaida E, Onizuka M, Mori T, Fujisawa S, Fujiwara SI, Saito T, Hagihara M, Aotsuka N, Gotoh M, Usuki K, Tsukada N, Kanda J, Kanamori H, Kanda Y, Okamoto S; Kanto Study Group for Cell Therapy (KSGCT).

Bone Marrow Transplant. 2019 Sep 19. doi: 10.1038/s41409-019-0689-8. [Epub ahead of print] No abstract available.

PMID:
31537900
22.

Comparison between the Bouchama and Japanese Association for Acute Medicine Heatstroke Criteria with Regard to the Diagnosis and Prediction of Mortality of Heatstroke Patients: A Multicenter Observational Study.

Kondo Y, Hifumi T, Shimazaki J, Oda Y, Shiraishi SI, Hayashida K, Fukuda T, Wakasugi M, Kanda J, Moriya T, Yagi M, Kawahara T, Tonouchi M, Yokobori S, Yokota H, Miyake Y, Shimizu K.

Int J Environ Res Public Health. 2019 Sep 16;16(18). pii: E3433. doi: 10.3390/ijerph16183433.

23.

Impact of Homozygous Conserved Extended HLA Haplotype on Single Cord Blood Transplantation: Lessons for Induced Pluripotent Stem Cell Banking and Transplantation in Allogeneic Settings.

Morishima Y, Morishima S, Murata M, Arima N, Uchida N, Sugio Y, Takahashi S, Matsuhashi Y, Onizuka M, Eto T, Nagafuji K, Onishi Y, Inoue M, Atsuta Y, Fukuda T, Ichinohe T, Kato S, Kanda J.

Biol Blood Marrow Transplant. 2020 Jan;26(1):132-138. doi: 10.1016/j.bbmt.2019.09.009. Epub 2019 Sep 12.

PMID:
31521817
24.

Biogeochemical controls of surface ocean phosphate.

Martiny AC, Lomas MW, Fu W, Boyd PW, Chen YL, Cutter GA, Ellwood MJ, Furuya K, Hashihama F, Kanda J, Karl DM, Kodama T, Li QP, Ma J, Moutin T, Woodward EMS, Moore JK.

Sci Adv. 2019 Aug 28;5(8):eaax0341. doi: 10.1126/sciadv.aax0341. eCollection 2019 Aug.

25.

Recent progress in haploidentical transplantation: is this the optimal choice for alternative donor transplantation?

Watanabe M, Kanda J.

Curr Opin Hematol. 2019 Nov;26(6):406-412. doi: 10.1097/MOH.0000000000000532.

PMID:
31483332
26.

Significance of FLT3-tyrosine kinase domain mutation as a prognostic factor for acute myeloid leukemia.

Sakaguchi M, Yamaguchi H, Kuboyama M, Najima Y, Usuki K, Ueki T, Oh I, Mori S, Kawata E, Uoshima N, Kobayashi Y, Kako S, Tajika K, Shono K, Kayamori K, Hagihara M, Kanda J, Uchiyama H, Kuroda J, Uchida N, Kubota Y, Kimura S, Kurosawa S, Date K, Nakajima N, Marumo A, Omori I, Fujiwara Y, Terada K, Yui S, Wakita S, Arai K, Kitano T, Kakihana K, Kanda Y, Ohashi K, Fukuda T, Inokuchi K.

Int J Hematol. 2019 Nov;110(5):566-574. doi: 10.1007/s12185-019-02720-z. Epub 2019 Aug 20.

PMID:
31432396
27.

Prognostic factors for adult single cord blood transplantation among European and Japanese populations: the Eurocord/ALWP-EBMT and JSHCT/JDCHCT collaborative study.

Kanda J, Hayashi H, Ruggeri A, Kimura F, Volt F, Takahashi S, Labopin M, Kako S, Tozatto-Maio K, Yano S, Sanz G, Uchida N, Van Lint MT, Kato S, Mohty M, Forcade E, Kanamori H, Sierra J, Ohno Y, Saccardi R, Fukuda T, Ichinohe T, Takanashi M, Rocha V, Okamoto S, Nagler A, Atsuta Y, Gluckman E.

Leukemia. 2020 Jan;34(1):128-137. doi: 10.1038/s41375-019-0534-5. Epub 2019 Aug 14.

PMID:
31409921
28.

Impact of High-Frequency HLA Haplotypes on Clinical Cytomegalovirus Reactivation in Allogeneic Hematopoietic Stem Cell Transplantation.

Kawase T, Tanaka H, Kojima H, Uchida N, Ohashi K, Fukuda T, Ozawa Y, Ikegame K, Eto T, Mori T, Miyamoto T, Hidaka M, Shiratori S, Takanashi M, Atsuta Y, Ichinohe T, Kanda Y, Kanda J; HLA Working Group of the Japan Society for Hematopoietic Cell Transplantation.

Biol Blood Marrow Transplant. 2019 Dec;25(12):2482-2489. doi: 10.1016/j.bbmt.2019.07.042. Epub 2019 Aug 7.

PMID:
31400501
29.

Serum ferritin levels at diagnosis predict prognosis in patients with low blast count myelodysplastic syndromes.

Kawabata H, Usuki K, Shindo-Ueda M, Kanda J, Tohyama K, Matsuda A, Araseki K, Hata T, Suzuki T, Kayano H, Shimbo K, Chiba S, Ishikawa T, Arima N, Nohgawa M, Miyazaki Y, Kurokawa M, Arai S, Mitani K, Takaori-Kondo A; Japanese National Research Group on Idiopathic Bone Marrow Failure Syndromes.

Int J Hematol. 2019 Nov;110(5):533-542. doi: 10.1007/s12185-019-02710-1. Epub 2019 Jul 29.

PMID:
31359362
30.

Spatial variation in sedimentary radioactive cesium concentrations in Tokyo Bay following the Fukushima Daiichi Nuclear Power Plant accident.

Kubo A, Tanabe K, Ito Y, Ishimaru T, Arakawa H, Kanda J.

Chemosphere. 2019 Nov;235:550-555. doi: 10.1016/j.chemosphere.2019.06.215. Epub 2019 Jun 28.

PMID:
31279117
31.

Allogeneic hematopoietic cell transplantation for patients with a history of multiple relapses of acute myeloid leukemia.

Yanada M, Mori J, Aoki J, Masuko M, Harada K, Uchida N, Doki N, Fukuda T, Sakura T, Kanamori H, Sawa M, Kondo T, Katayama Y, Kanda J, Ichinohe T, Atsuta Y, Yano S.

Ann Hematol. 2019 Sep;98(9):2179-2186. doi: 10.1007/s00277-019-03736-5. Epub 2019 Jun 15.

PMID:
31203422
32.

BM is preferred over PBSCs in transplantation from an HLA-matched related female donor to a male recipient.

Nakasone H, Kawamura K, Yakushijin K, Shinohara A, Tanaka M, Ohashi K, Ota S, Uchida N, Fukuda T, Nakamae H, Matsuoka KI, Kanda J, Ichinohe T, Atsuta Y, Inamoto Y, Seo S, Kimura F, Ogata M.

Blood Adv. 2019 Jun 11;3(11):1750-1760. doi: 10.1182/bloodadvances.2019000077.

33.

Prognostic index for patients with relapsed or refractory acute myeloid leukemia who underwent hematopoietic cell transplantation: a KSGCT multicenter analysis.

Tachibana T, Kanda J, Ishizaki T, Najima Y, Tanaka M, Doki N, Fujiwara SI, Kimura SI, Onizuka M, Takahashi S, Saito T, Mori T, Fujisawa S, Sakaida E, Matsumoto K, Aotsuka N, Goto M, Watanabe R, Shono K, Usuki K, Tsukada N, Kanamori H, Kanda Y, Okamoto S; Kanto Study; Group for Cell Therapy (KSGCT).

Leukemia. 2019 Nov;33(11):2610-2618. doi: 10.1038/s41375-019-0494-9. Epub 2019 May 30.

PMID:
31147621
34.

Guest Editorial: Are "alternative" stem cell sources still alternative in the new era?

Kanda J.

Int J Hematol. 2019 Jul;110(1):20-21. doi: 10.1007/s12185-019-02671-5. Epub 2019 May 28. No abstract available.

PMID:
31140118
35.

Examination of the Catabolic Rates of 13C-Labeled Fatty Acids Bound to the α and β Positions of Triacylglycerol Using 13CO2 Expired from Mice.

Yoshinaga K, Beppu F, Yamatani Y, Kubo A, Yoshinaga-Kiriake A, Nagai T, Yoshida A, Kanda J, Gotoh N.

J Oleo Sci. 2019 Jun 6;68(6):591-598. doi: 10.5650/jos.ess19012. Epub 2019 May 16.

36.

Unit selection for umbilical cord blood transplantation for adults with acute myeloid leukemia in complete remission: a Japanese experience.

Yanada M, Konuma T, Kuwatsuka Y, Kondo T, Kawata T, Takahashi S, Uchida N, Miyakoshi S, Tanaka M, Ozawa Y, Sawa M, Nakamae H, Aotsuka N, Kanda J, Takanashi M, Kanda Y, Atsuta Y, Yano S.

Bone Marrow Transplant. 2019 Nov;54(11):1789-1798. doi: 10.1038/s41409-019-0539-8. Epub 2019 May 8.

PMID:
31068659
37.

Efficacy and safety of endovascular therapy by diluted contrast digital subtraction angiography in patients with chronic kidney disease.

Hayakawa N, Kodera S, Ohki N, Kanda J.

Heart Vessels. 2019 Nov;34(11):1740-1747. doi: 10.1007/s00380-019-01412-2. Epub 2019 Apr 15.

PMID:
30989328
38.

Efficacy of cilostazol for sick sinus syndrome to avoid permanent pacemaker implantation: A retrospective case-control study.

Sonoura T, Kodera S, Shakya S, Kanda J.

J Cardiol. 2019 Oct;74(4):328-332. doi: 10.1016/j.jjcc.2019.03.007. Epub 2019 Apr 11.

PMID:
30982679
39.

Outcomes of second allogeneic haematopoietic stem cell transplantation in patients with relapse of myelodysplastic syndrome.

Shimomura Y, Hara M, Tachibana T, Ohashi K, Sakura T, Fukuda T, Nakazawa H, Iwato K, Kanda Y, Ikeda T, Eto T, Kanda J, Ichinohe T, Atsuta Y, Ishikawa T, Ishiyama K.

Br J Haematol. 2019 Jul;186(1):86-90. doi: 10.1111/bjh.15898. Epub 2019 Apr 2.

PMID:
30941758
40.

Mechanisms of radiocesium depuration in Sebastes cheni derived by simulation analysis of measured 137Cs concentrations off southern Fukushima 2014-2016.

Ishimaru T, Tateda Y, Tsumune D, Aoyama M, Hamajima Y, Kasamatsu N, Yamada M, Yoshimura T, Mizuno T, Kanda J.

J Environ Radioact. 2019 Jul;203:200-209. doi: 10.1016/j.jenvrad.2019.03.012. Epub 2019 Mar 27.

PMID:
30927563
41.

Short-term clinical outcomes after HLA 1-locus mismatched uPBSCT are similar to that after HLA-matched uPBSCT and uBMT.

Fuji S, Miyamura K, Kanda Y, Fukuda T, Kobayashi T, Ozawa Y, Iwato K, Uchida N, Eto T, Ashida T, Mori T, Sawa M, Ichinohe T, Atsuta Y, Kanda J; HLA Working Group of the Japan Society for Hematopoietic Cell Transplantation.

Int J Hematol. 2019 Jun;109(6):684-693. doi: 10.1007/s12185-019-02631-z. Epub 2019 Mar 15.

PMID:
30877606
42.

ABO blood type incompatibility lost the unfavorable impact on outcome in unrelated bone marrow transplantation.

Kimura F, Kanda J, Ishiyama K, Yabe T, Yoshifuji K, Fukuda T, Ozawa Y, Iwato K, Eto T, Mori T, Uchida N, Ota S, Sakura T, Ichinohe T, Atsuta Y, Kanda Y; donor/source working group of the Japan Society for Hematopoietic Cell Transplantation.

Bone Marrow Transplant. 2019 Oct;54(10):1676-1685. doi: 10.1038/s41409-019-0496-2. Epub 2019 Mar 13.

PMID:
30867557
43.

Cytomegalovirus reactivation is associated with increased mortality more than 100 days after allogeneic hematopoietic stem cell transplantation for adult T-cell leukemia/lymphoma.

Sawayama Y, Itonaga H, Fukushima T, Nakano N, Fujiwara H, Utsunomiya A, Fukuda T, Miyamoto T, Eto T, Miyashita K, Nakamae H, Ogata M, Yamanoha A, Miyazaki Y, Kanda J, Atsuta Y, Kato K; ATL Working Group of the Japan Society for Hematopoietic Cell Transplantation.

Am J Hematol. 2019 May;94(5):E143-E146. doi: 10.1002/ajh.25438. Epub 2019 Mar 6. No abstract available.

PMID:
30773707
44.

Clinical significance of low-dose total body irradiation in HLA-mismatched reduced-intensity stem cell transplantation.

Fujiwara SI, Kanda J, Tatara R, Ogawa H, Fukuda T, Okumura H, Ohashi K, Iwato K, Ueda Y, Ishiyama K, Eto T, Matsuoka KI, Nakamae H, Onizuka M, Atsuta Y, Kanda Y; HLA Working Group of the Japan Society for Hematopoietic Cell Transplantation.

Bone Marrow Transplant. 2019 Aug;54(8):1327-1336. doi: 10.1038/s41409-019-0434-3. Epub 2019 Jan 22.

PMID:
30670824
45.

Impact of cumulative steroid dose on infectious diseases after allogenic hematopoietic stem cell transplantation.

Watanabe M, Kanda J, Hishizawa M, Kondo T, Yamashita K, Takaori-Kondo A.

Transpl Infect Dis. 2019 Apr;21(2):e13049. doi: 10.1111/tid.13049. Epub 2019 Feb 6.

PMID:
30656802
46.

Effect of laminar air flow and building construction on aspergillosis in acute leukemia patients: a retrospective cohort study.

Iwasaki M, Kanda J, Hishizawa M, Kitano T, Kondo T, Yamashita K, Takaori-Kondo A.

BMC Infect Dis. 2019 Jan 9;19(1):38. doi: 10.1186/s12879-018-3665-9.

47.

Haploidentical transplantation using low-dose alemtuzumab: Comparison with haploidentical transplantation using low-dose thymoglobulin.

Kako S, Gomyo A, Akahoshi Y, Harada N, Kameda K, Ugai T, Wada H, Ishihara Y, Kawamura K, Sakamoto K, Sato M, Terasako-Saito K, Kimura SI, Kikuchi M, Nakasone H, Kanda J, Kanda Y.

Eur J Haematol. 2019 Mar;102(3):256-264. doi: 10.1111/ejh.13204. Epub 2019 Jan 9.

PMID:
30578673
48.

HLA discrepancy between graft and host rather than that graft and first donor impact the second transplant outcome.

Maeda Y, Ugai T, Kondo E, Ikegame K, Murata M, Uchida N, Miyamoto T, Takahashi S, Ohashi K, Nakamae H, Fukuda T, Onizuka M, Eto T, Ota S, Hirokawa M, Ichinohe T, Atsuta Y, Kanda Y, Kanda J; HLA Working Group of the Japan Society for Hematopoietic Cell Transplantation.

Haematologica. 2019 May;104(5):1055-1061. doi: 10.3324/haematol.2018.204438. Epub 2018 Dec 6.

49.

Endovascular Therapy Using Diluted Contrast Medium for Critical Limb Ischemia in a Patient with Chronic Kidney Disease.

Hayakawa N, Kodera S, Ohki N, Kushida S, Morita H, Kanda J, Komuro I.

Int Heart J. 2019 Jan 25;60(1):226-230. doi: 10.1536/ihj.18-125. Epub 2018 Nov 20.

50.

Prognostic impact of melphalan dose and total body irradiation use in patients with acute myeloid leukemia undergoing allogeneic stem cell transplantation with reduced-intensity conditioning.

Harada K, Yanada M, Machida S, Kanamori H, Onizuka M, Ozawa Y, Kobayashi H, Sawa M, Katayama Y, Ohashi K, Kanda J, Ichinohe T, Atsuta Y, Yano S.

Leuk Lymphoma. 2019 Jun;60(6):1493-1502. doi: 10.1080/10428194.2018.1535115. Epub 2018 Nov 20.

PMID:
30457400

Supplemental Content

Support Center